{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:20:36Z","timestamp":1767856836269,"version":"3.49.0"},"reference-count":28,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Pulmonology"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>To help open the clinician dialogue regarding cannabis use in persons with cystic fibrosis (CF) in the United States, we aimed to describe current practices of use assessment and documentation processes related to cannabis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross\u2010sectional, anonymous survey study was distributed via email to CF directors and coordinators and to the Cystic Fibrosis Foundation (CFF) listservs of nurse, pharmacist, dietitian, social worker, and psychology care team members. The survey tool included multiple choice, scaled, and open\u2010ended items, which assessed participants' awareness of current cannabis laws in their state, prescribing practices for medical marijuana, screening and documentation practices, knowledge of and what indications participants believe cannabis and cannabidiol (CBD) could be beneficial. Data were analyzed using descriptive statistics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 282 survey participants, with majority as providers (28%) and social workers (29%), representing all US regions. Participants varied in terms of frequency of evaluating cannabis use, with 15.4% \u201calways,\u201d 48.4% \u201csometimes,\u201d and 41% \u201crarely,\u201d or \u201cnever\u201d asking about it. Regarding recreational versus medical cannabis use, 55.4% and 62.5% reported documentation of each type in the medical record, respectively. Participants reported appetite, pain, and nausea as the top three advocated indications for use. About 35% and 72% of participants felt \u201cslightly\u201d or \u201cnot at all\u201d prepared to answer patient\/family questions about cannabis and CBD, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The approach to cannabis use assessment, documentation, and education across CF care centers is variable. There is a need for care team and patient\/caregiver education materials about cannabis\/CBD and CF.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ppul.25563","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T17:25:02Z","timestamp":1625678702000},"page":"2879-2887","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A clinician survey of use assessment, documentation, and education about cannabis in persons with cystic fibrosis"],"prefix":"10.1002","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6269-6459","authenticated-orcid":false,"given":"Corinne A","family":"Muirhead","sequence":"first","affiliation":[{"name":"Department of Pharmacy Oregon Health &amp; Sciences University, Doernbecher Children's Hospital Portland Oregon USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Palmrose","sequence":"additional","affiliation":[{"name":"Oregon Health &amp; Science University Portland Oregon USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Condren","sequence":"additional","affiliation":[{"name":"Department of Pediatrics University of Oklahoma School of Community Medicine Oklahoma City Oklahoma USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon M.","family":"Rotolo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy University of Chicago Medicine Chicago Illinois USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6049-0481","authenticated-orcid":false,"given":"Rebecca S.","family":"Pettit","sequence":"additional","affiliation":[{"name":"Riley Hospital for Children at IU Health Indianapolis Indiana USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsain","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, School of Medicine Yale University New Haven Connecticut USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4968-1460","authenticated-orcid":false,"given":"Hanna","family":"Phan","sequence":"additional","affiliation":[{"name":"The University of Michigan College of Pharmacy, Michigan Medicine C.S. Mott Children's Hospital Ann Arbor Michigan USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.293"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.3.9701026"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201212-127FR"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.03.031"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2019.09.008"},{"key":"e_1_2_8_7_1","unstructured":"Cystic Fibrosis.Canada's Position on Cannabis in the Treatment of Cystic Fibrosis; 2018.https:\/\/www.cysticfibrosis.ca\/news\/cf-canadas-position-on-cannabis-in-treatment-cf. Accessed October 17 2018."},{"key":"e_1_2_8_8_1","unstructured":"State medical marijuana laws.National Conference of State Legislatures Web site;\u00a02020.https:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx. Accessed January 2021."},{"key":"e_1_2_8_9_1","unstructured":"US Food and Drug Administration. FDAapproves first drug comprised of an active ingredient derived from marijunana to treat rare severe forms of epilepsy.FDA News Release;2018.https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-020-03116-x"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-4-371"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-0722"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.2.250"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80090-2"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2018.06.008"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1300\/J175v02n01_03"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.01.023"},{"key":"e_1_2_8_20_1","article-title":"CB2 Agonist, Lenabasum, for the treatment of pulmonary exacerbations in cystic fibrosis","author":"Chmiel JFKM","year":"2020","journal-title":"Poster presented at NACFC"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1049909115604669"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2013.01.120089"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.01.059"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.010"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-0667-2"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2015.01.059"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicines6010003"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13710"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2155-8256(18)30083-8"}],"container-title":["Pediatric Pulmonology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.25563","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ppul.25563","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ppul.25563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T09:11:53Z","timestamp":1692954713000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ppul.25563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1002\/ppul.25563"],"URL":"https:\/\/doi.org\/10.1002\/ppul.25563","archive":["Portico"],"relation":{},"ISSN":["8755-6863","1099-0496"],"issn-type":[{"value":"8755-6863","type":"print"},{"value":"1099-0496","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2021-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}